Home  |  Contact

UniProtKB/Swiss-Prot P02751: Variant p.Cys260Gly

Fibronectin
Gene: FN1
Variant information

Variant position:  260
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  LP/P [Disclaimer]
The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change:  From Cysteine (C) to Glycine (G) at position 260 (C260G, p.Cys260Gly).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from medium size and polar (C) to glycine (G)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  -3
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description:  In SMDCF; the mutant is not secreted.
Any additional useful information about the variant.

Other resources:  
Links to websites of interest for the variant.



Sequence information

Variant position:  260
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  2477
The length of the canonical sequence.

Location on the sequence:   YRIGDTWSKKDNRGNLLQCI  C TGNGRGEWKCERHTSVQTTS
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         YRIGDTWSKKDNRGNLLQCICTGNGRGEWKCERHTSVQTTS

Mouse                         YRIGDTWSKKDNRGNLLQCVCTGNGRGEWKCERHA-LQSAS

Rat                           YRIGDTWSKKDNRGNLLQCVCTGNGRGEWKCERHV-LQSAS

Bovine                        YRIGDTWSKKDNRGNLLQCICTGNGRGEWKCERHTSLQTTS

Horse                         YRIGDTWSKKDNRGNLLQCICTGNGRGEWKCERHASLQTTS

Chicken                       YRIGDTWSKKDNRGNLLQCICTGNGRGEWKCERHTSLHTTS

Xenopus laevis                YRIGDTWSKTDTRGNLLQCICTGNGRGEWKCERHSSAQATG

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 32 – 2477 Fibronectin
Domain 229 – 273 Fibronectin type-I 5
Region 52 – 272 Fibrin- and heparin-binding 1
Glycosylation 279 – 279 O-linked (GalNAc...) threonine
Disulfide bond 231 – 260
Disulfide bond 258 – 270
Beta strand 255 – 262


Literature citations

Mutations in fibronectin cause a subtype of spondylometaphyseal dysplasia with 'corner fractures'.
Lee C.S.; Fu H.; Baratang N.; Rousseau J.; Kumra H.; Sutton V.R.; Niceta M.; Ciolfi A.; Yamamoto G.; Bertola D.; Marcelis C.L.; Lugtenberg D.; Bartuli A.; Kim C.; Hoover-Fong J.; Sobreira N.; Pauli R.; Bacino C.; Krakow D.; Parboosingh J.; Yap P.; Kariminejad A.; McDonald M.T.; Aracena M.I.; Lausch E.; Unger S.; Superti-Furga A.; Lu J.T.; Cohn D.H.; Tartaglia M.; Lee B.H.; Reinhardt D.P.; Campeau P.M.;
Am. J. Hum. Genet. 101:815-823(2017)
Cited for: SUBCELLULAR LOCATION; INVOLVEMENT IN SMDCF; VARIANTS SMDCF PHE-87; ARG-123; TRP-225; ASP-240; GLY-260 AND THR-809 DEL; CHARACTERIZATION OF VARIANTS SMDCF PHE-87; ASP-240 AND GLY-260;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.